Association between the LRP1B and APOE loci and the development of Parkinson’s disease dementia
By onGenetic analysis of 3,964 PD cases revealed APOE-ϵ4 allele and new loci as risk factors for PD dementia progression, implicating amyloid pathway in PDD development and potential for amyloid-targeting therapy.
Structure and activation of the human autophagy-initiating ULK1C:PI3KC3-C1 supercomplex
By onAuthors determine cryo-EM structure of human ULK1C core and its complex with PI3KC3-C1. ULK1C core undergoes a rearrangement from 2:1:1 to 2:2:2 stoichiometry, suggesting a structural mechanism for autophagy initiation.
A549 PPM1H-BromoTag (CVCL_C8YV)
By onCell Line: PPM1H-BromoTag CRISPR/CAS9 A549 knock-in cell line generated from parental A549 cells (ATCC A549 CCl-185) by introducing a BromoTag linked to the C-terminus of PPM1H using CRISPR/Cas9 gene-editing technology.
Post mortem human substantial nigra TH staining
By onThis protocol is standardized for postmortem (frozen) SN tissue from pathologically diagnosed PD patients and control individuals for Immunofluorescence staining.
GFP-TBK1: expression and purification
By onThis protocol describes how to express and purify human TBK1 tagged N-terminally with eGFP.
The Hsc70 disaggregation machinery removes monomer units directly from α-synuclein fibril ends
By onUsing microfluidic diffusional sizing, the authors show that the molecular chaperone family Hsp70 (specifically Hsc70, DnaJB, and Apg2) can completely dissolve alpha-synuclein aggregation and revert it back to its monomeric state.
ImageJ FIJI code to semi-automatize the morphological analysis of microglia in histological sections
By onImageJ FIJI code to semi-automatize the morphological analysis of microglia in histological sections.
Immunohistochemistry of AAV-treated tissues
By onOutlines procedures to perform immunohistochemistry on tissue that had been treated with AAV.
Evaluation of mtKeima foci in induced neurons (iNeurons)
By onAssociated with preprint: https://www.biorxiv.org/content/10.1101/2022.11.02.514817v1
Phenotypic effect of GBA1 variants in individuals with and without Parkinson disease: the RAPSODI study
By onThe authors’ results support previous evidence that GBA1-positive PD has a specific phenotype with more severe non-motor symptoms. The authors did not reproduce previous findings of more frequent prodromal PD signs in non-affected GBA1 carriers.
A feed-forward pathway drives LRRK2 kinase membrane recruitment and activation
By onLRRK2 interacts with Rab8A and Rab10 at specific binding sites, enhancing LRRK2 kinase activity on membranes. This feed-forward pathway regulates LRRK2 activation and substrate phosphorylation.
cDNA clones for expression of GolgiTag (TMEM115) in mammalian cells
By onPlasmids for expression of TMEM115 (GolgiTag) in human and mouse cells.
Fluorescent Immunolabelling for endogenous ChAT in mice striatum
By onThis immunohistochemistry protocol has been designed and adjusted specifically for ChAT immunolabelling in the mice striatum.
Immunofluorescent labeling of cultured cells
By onThis protocol describes the process of Paraformaldehyde fixation and immunofluorescent-labeling of cultured cells.
Unilateral intranigral AAV alpha synuclein mouse model
By onAs some protocols have not been made public and are only shared within the network, you may need to login to the protocols.io to view the link.Don’t have a login? Use this special invite link and click join to get started. Click here for detailed instructions on how to set up your free account and view all protocols.
Intracellular Cytokine (ICS) Staining Protocol
By onThis protocol details about intracellular cytokine (ICS) staining.
H9 ES AAVS1-NGN2 FAM134C/A/B-/-; PiggyBac-Keima-REEP5
By onES cells were modified to create iNeurons lacking FAM134C, A, B receptors and expressing Keima-REEP5 ER-phagy flux reporter. CRISPR/Cas9 was used to introduce NEUROG2 construct in AAVS1 locus and knockout RETREG1, 2, 3 genes.
Passaging of hPSCs grown on MEFs
By onThis protocol describes the standard procedure of using collagenase to passage human pluripotent stem cells (hPSCs) on inactivated mouse embryonic fibroblasts (MEFs).
